These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37165346)

  • 1. Artificial intelligence guided HRCT assessment predicts the severity of COVID-19 pneumonia based on clinical parameters.
    Chrzan R; Wizner B; Sydor W; Wojciechowska W; Popiela T; Bociąga-Jasik M; Olszanecka A; Strach M
    BMC Infect Dis; 2023 May; 23(1):314. PubMed ID: 37165346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of artificial intelligence technology analysis of high-resolution computed tomography images in predicting the severity of COVID-19 pneumonia.
    Chrzan R; Wojciechowska W; Terlecki M; Klocek M; Rajzer M; Popiela T
    Pol Arch Intern Med; 2022 Dec; 132(12):. PubMed ID: 36026617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of lung ultrasound in COVID-19 pneumonia, verified by high resolution computed tomography assessed by artificial intelligence.
    Chrzan R; Polok K; Antczak J; Siwiec-Koźlik A; Jagiełło W; Popiela T
    BMC Infect Dis; 2023 Mar; 23(1):195. PubMed ID: 37003997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic status affects the severity of coronavirus disease 2019 in patients with diabetes mellitus: an observational study of CT radiological manifestations using an artificial intelligence algorithm.
    Lu X; Cui Z; Pan F; Li L; Li L; Liang B; Yang L; Zheng C
    Acta Diabetol; 2021 May; 58(5):575-586. PubMed ID: 33420614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary SARS-CoV-2 Pneumonia Screening in Adults: Analysis of the Correlation Between High-Resolution Computed Tomography Pulmonary Patterns and Initial Oxygen Saturation Levels.
    Alonazi B; Mostafa MA; Farghaly AM; Zindani SA; Al-Watban JA; Altaimi F; Almotairy AS; Fagiry MA; Mahmoud MZ
    Curr Med Imaging; 2022; 19(5):486-493. PubMed ID: 35927895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of COVID-19 Opacities on Chest CT - Evaluation of a Fully Automatic AI-approach to Noninvasively Differentiate Critical Versus Noncritical Patients.
    Mader C; Bernatz S; Michalik S; Koch V; Martin SS; Mahmoudi S; Basten L; Grünewald LD; Bucher A; Albrecht MH; Vogl TJ; Booz C
    Acad Radiol; 2021 Aug; 28(8):1048-1057. PubMed ID: 33741210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial intelligence-based CT metrics used in predicting clinical outcome of COVID-19 in young and middle-aged adults.
    Xudong Y; Weihong L; Feng X; Yanli L; Weishun L; Fengjun Z; Jiao G; Jiawei L; Xiaolu H; Huailiang H; Jianye L; Sihui Z; Chuanmiao X; Hanhui L; Liang M
    Med Phys; 2022 Aug; 49(8):5604-5615. PubMed ID: 35689830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences among COVID-19, Bronchopneumonia and Atypical Pneumonia in Chest High Resolution Computed Tomography Assessed by Artificial Intelligence Technology.
    Chrzan R; Bociąga-Jasik M; Bryll A; Grochowska A; Popiela T
    J Pers Med; 2021 May; 11(5):. PubMed ID: 34068751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utilization of artificial intelligence-based COVID-19 pneumonia quantification using chest computed tomography - a multicenter retrospective cohort study in Japan.
    Tanaka H; Maetani T; Chubachi S; Tanabe N; Shiraishi Y; Asakura T; Namkoong H; Shimada T; Azekawa S; Otake S; Nakagawara K; Fukushima T; Watase M; Terai H; Sasaki M; Ueda S; Kato Y; Harada N; Suzuki S; Yoshida S; Tateno H; Yamada Y; Jinzaki M; Hirai T; Okada Y; Koike R; Ishii M; Hasegawa N; Kimura A; Imoto S; Miyano S; Ogawa S; Kanai T; Fukunaga K
    Respir Res; 2023 Oct; 24(1):241. PubMed ID: 37798709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial intelligence-based analysis of the spatial distribution of abnormal computed tomography patterns in SARS-CoV-2 pneumonia: association with disease severity.
    Kataoka Y; Tanabe N; Shirata M; Hamao N; Oi I; Maetani T; Shiraishi Y; Hashimoto K; Yamazoe M; Shima H; Ajimizu H; Oguma T; Emura M; Endo K; Hasegawa Y; Mio T; Shiota T; Yasui H; Nakaji H; Tsuchiya M; Tomii K; Hirai T; Ito I
    Respir Res; 2024 Jan; 25(1):24. PubMed ID: 38200566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of clinical features and imaging signs of COVID-19 with the assistance of artificial intelligence.
    Ren HW; Wu Y; Dong JH; An WM; Yan T; Liu Y; Liu CC
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8210-8218. PubMed ID: 32767351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT quantification of COVID-19 pneumonia extent to predict individualized outcome.
    Berecova Z; Juskanic D; Hazlinger M; Uhnak M; Janega P; Rudnay M; Hatala R
    Bratisl Lek Listy; 2024; 125(3):159-165. PubMed ID: 38385541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Involvement in SARS-CoV-2 Infection Estimates Myocardial Injury Risk.
    Dumea E; Lazar M; Barbu EC; Chitu CE; Ion DA
    Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295594
    [No Abstract]   [Full Text] [Related]  

  • 15. CT Quantitative Analysis and Its Relationship with Clinical Features for Assessing the Severity of Patients with COVID-19.
    Sun D; Li X; Guo D; Wu L; Chen T; Fang Z; Chen L; Zeng W; Yang R
    Korean J Radiol; 2020 Jul; 21(7):859-868. PubMed ID: 32524786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
    Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
    PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the Impact of Inflammatory Markers and CT Severity Score on Disease Severity of COVID-19 Patients Admitted to ICU at a Tertiary Hospital.
    Kurri N; Tyagi B; Singhal E; Gupta N; Agarwal AK; Gupta V; Rai G; Bindra MS
    J Assoc Physicians India; 2021 Jun; 69(6):11-12. PubMed ID: 34472783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial intelligence-assisted quantification of COVID-19 pneumonia burden from computed tomography improves prediction of adverse outcomes over visual scoring systems.
    Grodecki K; Killekar A; Simon J; Lin A; Cadet S; McElhinney P; Chan C; Williams MC; Pressman BD; Julien P; Li D; Chen P; Gaibazzi N; Thakur U; Mancini E; Agalbato C; Munechika J; Matsumoto H; Menè R; Parati G; Cernigliaro F; Nerlekar N; Torlasco C; Pontone G; Maurovich-Horvat P; Slomka PJ; Dey D
    Br J Radiol; 2023 Sep; 96(1149):20220180. PubMed ID: 37310152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil to lymphocytic ratio and other inflammatory markers as adverse outcome predictor in hospitalized COVID-19 patients.
    Abdelhady SA; Rageh F; Ahmed SS; Al-Touny SA; Riad E; Elhoseeny MM; Khalifa AA; Salim A; Farghly MI; Elgamal R
    Egypt J Immunol; 2022 Apr; 29(2):57-67. PubMed ID: 35436055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.